Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Abvc Biopharma (ABVC) over the last 13 years, with Q3 2025 value amounting to -$274219.0.

  • Abvc Biopharma's Net Cash Flow fell 125709.1% to -$274219.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $281545.0, marking a year-over-year decrease of 1836.72%. This contributed to the annual value of $171624.0 for FY2024, which is 12534.79% up from last year.
  • Latest data reveals that Abvc Biopharma reported Net Cash Flow of -$274219.0 as of Q3 2025, which was down 125709.1% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Net Cash Flow ranged from a high of $2.8 million in Q3 2021 and a low of -$3.5 million during Q2 2022
  • In the last 5 years, Abvc Biopharma's Net Cash Flow had a median value of -$237869.0 in 2023 and averaged -$344758.0.
  • Examining YoY changes over the last 5 years, Abvc Biopharma's Net Cash Flow showed a top increase of 121199.54% in 2021 and a maximum decrease of 794008.37% in 2021.
  • Quarter analysis of 5 years shows Abvc Biopharma's Net Cash Flow stood at $2.2 million in 2021, then plummeted by 137.02% to -$797857.0 in 2022, then soared by 70.19% to -$237869.0 in 2023, then tumbled by 54.0% to -$366312.0 in 2024, then rose by 25.14% to -$274219.0 in 2025.
  • Its Net Cash Flow stands at -$274219.0 for Q3 2025, versus $1.0 million for Q2 2025 and -$111077.0 for Q1 2025.